2064

NEW ZEALAND GAZETTE

No. 78

2. Interpretation—Terms used in this notice have the same meaning as defined in the Fisheries (South Tasman Rise Orange Roughy Fishery) Regulations 2000.

3. Annual catch limit varied—The annual catch limit for the high seas area of the South Tasman Rise orange roughy fishery for the season that commenced on 1 March 2003 is decreased to 100 greenweight tonnes.

4. Date of variation—The varied annual catch limit takes effect on 14 July 2003.

5. Revocation—The Fisheries (South Tasman Rise Orange Roughy Fishery Annual Catch Limit) Notice 2003 (No. F238) which appeared in the New Zealand Gazette, 27 February 2003, page 493, is revoked.

Dated at Wellington this 8th day of July 2003.

JANE WILLING, Manager International & Biosecurity, Ministry of Fisheries (acting under delegated authority from the Chief Executive, Ministry of Fisheries).

go4401

Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Strepfen Sugar Free Cherry Lozenge

Active Ingredient: Flurbiprofen 8.75mg

Dosage Form: Lozenge

New Zealand Sponsor: Boots Healthcare New Zealand Limited

Manufacturer: Boots Contract Manufacturers, Nottingham, England

Product: Strepfen Sugar Free Orange Lozenge

Active Ingredient: Flurbiprofen 8.75mg

Dosage Form: Lozenge

New Zealand Sponsor: Boots Healthcare New Zealand Limited

Manufacturer: Boots Contract Manufacturers, Nottingham, England

Dated this 2nd day of July 2003.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go4286

Classification of Medicines

Pursuant to section 106 (1) of the Medicines Act 1981, I, G. R. Boyd, Chief Advisor, Safety and Regulation, acting under delegated authority, hereby declare the following:

1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.

2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.

3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is an injection or eye preparation, to any concentration of that medicine; and

(ii) if the medicine is not an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1

Prescription Medicines

Acepromazine

Adalimumab

Alefacept

Adenosine; for injection

Amethocaine; for internal use; for external use in medicines containing more than 10%; for ophthalmic use except when used in practice by a registered optometrist

Amylocaine

Aristolochic acid; at all strengths

Atomoxetine

Atropa belladonna; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram

Atropine; except when specified elsewhere in the Schedule; except when used as an antidote in a device designed for